Does DACLIZUMAB Cause Transplant dysfunction? 421 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 421 reports of Transplant dysfunction have been filed in association with DACLIZUMAB. This represents 15.0% of all adverse event reports for DACLIZUMAB.
421
Reports of Transplant dysfunction with DACLIZUMAB
15.0%
of all DACLIZUMAB reports
3
Deaths
8
Hospitalizations
How Dangerous Is Transplant dysfunction From DACLIZUMAB?
Of the 421 reports, 3 (0.7%) resulted in death, 8 (1.9%) required hospitalization, and 158 (37.5%) were considered life-threatening.
Is Transplant dysfunction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 421 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant rejection (385)
Acne (382)
Ovarian cyst (374)
Multiple sclerosis relapse (313)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
Liver function test abnormal (159)
What Other Drugs Cause Transplant dysfunction?
TACROLIMUS (944)
MYCOPHENOLATE MOFETIL (780)
CYCLOSPORINE (610)
SIROLIMUS (468)
ETANERCEPT (449)
INFLIXIMAB (405)
PREDNISONE (240)
TACROLIMUS\TACROLIMUS ANHYDROUS (198)
THYMOCYTE IMMUNE GLOBULIN NOS (190)
PREDNISOLONE (182)
Which DACLIZUMAB Alternatives Have Lower Transplant dysfunction Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN